Pharmaceuticals | Recruiting Section Editor-in-Chief for the “AI in Drug Development” Section

Pharmaceuticals (ISSN: 1424-8247) is recruiting a Section Editor-in-Chief for the Section “AI in Drug Development”.

Pharmaceuticals is a peer-reviewed, open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI. The Academy of Pharmaceutical Sciences (APS) is a partner of Pharmaceuticals and their members receive a discount on the article processing charge.

Section Editors-in-Chief are leaders in their particular field, and are responsible for ensuring the scientific quality of a particular Section of a journal. The Section Editor-in-Chief is expected to oversee the growth and development of the journal Section and their Board Members. The initial term for this position is 2 years, and it entails the following roles:

Acting as an ambassador for the journal, MDPI, and open access publishing;
Making scientific decisions about the scope of their Section;
Inviting distinguished scientists to join the Editorial Board;
Suggesting topics for Special Issues;
Providing support and guidance to Editorial Board Members and editorial staff when required;
Maintaining oversight of the editorial process for individual manuscripts in their Section (mainly by making the final decision regarding whether a paper can be published after undergoing peer review and revisions);
Understanding, leading, and upholding MDPI’s peer review guidelines and ethics guidelines.

This position is seeking distinguished experts in artificial intelligence (AI) and its application in drug discovery and development. The call for applications will remain open until the journal officially announces the Section Editor-in-Chief online. To apply for this position, recommend potential candidates, or request further information, please contact the Pharmaceuticals Editorial Office.

The “AI in Drug Development” Section is also recruiting Editorial Board Members (EBMs), Guest Editors, and volunteer reviewers. The relevant requirement information can be found at the following link:

We look forward to the opportunity to work with you.

Pharmaceuticals Editorial Office